<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610660</url>
  </required_header>
  <id_info>
    <org_study_id>TOPP-2</org_study_id>
    <nct_id>NCT02610660</nct_id>
  </id_info>
  <brief_title>Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension</brief_title>
  <acronym>TOPP-2</acronym>
  <official_title>Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association for Pediatric Pulmonary Hypertension</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association for Pediatric Pulmonary Hypertension</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The TOPP-2 registry is an international, non-interventional, prospective registry including&#xD;
      children and adolescents newly diagnosed with pulmonary hypertension (PH) to gain further&#xD;
      insights in the disease course and long-term outcome of PH in childhood.&#xD;
&#xD;
      Patients will undergo clinical assessments and receive standard medical care, as determined&#xD;
      by treating physicians in their daily clinical practice. The TOPP-2 registry is specifically&#xD;
      designed to capture the variables that have been proposed as treatment goals in PePH and the&#xD;
      reasons for changes in treatment strategy.&#xD;
&#xD;
      The TOPP-2 registry uses the new clinical classification of PH as outlined at the 5th World&#xD;
      Symposium for Pulmonary Hypertension (WSPH) in Nice 2013 and includes new characterizations&#xD;
      for children with PH.&#xD;
&#xD;
      The registry is planned and implemented under the scientific leadership of the Association&#xD;
      for Pediatric Pulmonary Hypertension (PePH), independently from the financial sponsors.&#xD;
&#xD;
      All enrolled patients will have a follow-up period of 18 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Transplantation</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation related to pulmonary arterial hypertension (PAH)</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use/initiation of i.v./s.c. prostanoids</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial septostomy</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potts shunt</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to clinical worsening</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
    <description>Various composites of above parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decline in 6-minute walk test (6MWT)</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of treatment</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
    <description>Type of treatment (drug, mono/combination, administration route)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Switch in treatment</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Escalation of treatment</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for treatment change</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decline in WHO functional class</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decline in Panama functional class</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worsening of echocardiographic parameters (ECHO)</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
    <description>Parameters encompass TAPSE and RV/LV dimension ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in Brain Natriuretic Peptide (BNP)</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in N-terminal-proBNP (NT-proBNP)</measure>
    <time_frame>Over registry run-time (5.5 years)</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">388</enrollment>
  <condition>Hypertension, Pulmonary</condition>
  <eligibility>
    <study_pop>
      <textblock>
        1. Children and adolescents, newly diagnosed with PH (incident PePH patients), meeting&#xD;
             the inclusion criteria. A patient is considered an incident patient if the time&#xD;
             elapsed between the diagnostic RHC and the initial visit at the site including the&#xD;
             patient is less than or equal to three months and if the time between diagnostic RHC&#xD;
             and informed consent is less than or equal to six months&#xD;
&#xD;
          2. Ex-incident patients from the previous TOPP-1 registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must be an incident patient, i.e.newly diagnosed with PH&#xD;
&#xD;
          -  Age at time of diagnosis is at least 3 months and less than 18 years&#xD;
&#xD;
          -  Patients must present with PH belonging to one of the following categories&#xD;
&#xD;
               -  Group 1 according to updated Nice clinical classification&#xD;
&#xD;
               -  Group 3 according to updated Nice clinical classification&#xD;
&#xD;
               -  Group 4 according to updated Nice clinical classification&#xD;
&#xD;
               -  Group 5 according to updated Nice clinical classification&#xD;
&#xD;
          -  PH confirmed by heart catheterisation (HC)&#xD;
&#xD;
          -  At HC, the patient must present with mean pulmonary arterial pressure (PAP) of at&#xD;
             least 25 mmHg at rest, a pulmonary vascular resistance index (PVRi) equal to or below&#xD;
             3 Wood units*m^2 and mean pulmonary arterial wedge pressure (PAWP) below or equal to&#xD;
             15 mmHg&#xD;
&#xD;
          -  In case of congenital heart disease (CHD) patients who had undergone palliative&#xD;
             procedure or repair to close systemic to pulmonary shunt, the diagnosis of PH must&#xD;
             have been confirmed by HC at least 6 months after surgery/palliative procedure took&#xD;
             place&#xD;
&#xD;
          -  For patients with PAH-CHD open shunt, only those considered not operable due to&#xD;
             advanced pulmonary vascular disease are eligible&#xD;
&#xD;
          -  Patients to be included into the registry, and/or their legal guardians, must give&#xD;
             informed consent. Where applicable patients will be asked for their written assent&#xD;
&#xD;
          -  Participating sites must agree to adhere to the recommendations of the WSPH 2015 Nice,&#xD;
             Pediatric Taskforce.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients belonging to Group 2 according to updated Nice clinical classification&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dunbar Ivy, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Association for Pediatric Pulmonary Hypertension</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Denver School of Medicine, Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Children's Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-9310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Melbourne</city>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1XB</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fu Wai Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Pediátrico La Misericordia</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Université Paris Descartes</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah, Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Padova</name>
      <address>
        <city>Padova</city>
        <zip>35127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toho Universit Omori Medical Center</name>
      <address>
        <city>Tokyo</city>
        <zip>1438541</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keio University</name>
      <address>
        <city>Tokyo</city>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Heart Institute</name>
      <address>
        <city>Mexico City</city>
        <zip>14050</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beatrix Children's Hospital, University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial</name>
      <address>
        <city>Warsaw</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahd Armed Forces Hospital</name>
      <address>
        <city>Jeddah</city>
        <zip>23311</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Queen Silvia's Children's Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Saudi Arabia</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.peph-association.org/</url>
    <description>Webpage of the Association for Pediatric Pulmonary Hypertension</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

